Form 8-K - Current report:
SEC Accession No. 0001144204-19-030502
Filing Date
2019-06-11
Accepted
2019-06-11 08:00:12
Documents
4
Period of Report
2019-06-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv523383_8k.htm 8-K 34442
2 EXHIBIT 3.1 tv523383_ex3-1.htm EX-3.1 5870
3 EXHIBIT 99.1 tv523383_ex99-1.htm EX-99.1 11695
4 GRAPHIC image_001.jpg GRAPHIC 3748
  Complete submission text file 0001144204-19-030502.txt   59058
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36860 | Film No.: 19889919
SIC: 2836 Biological Products, (No Diagnostic Substances)